Loading AI tools
British physician scientist From Wikipedia, the free encyclopedia
Robert Charles Swanton is a British physician scientist specialising in oncology and cancer research. Swanton is a senior group leader at London's Francis Crick Institute,[3] Royal Society Napier Professor in Cancer[4] and thoracic medical oncologist at University College London[5] and University College London Hospitals,[6][7] co-director of the Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, and Chief Clinician of Cancer Research UK.[8][9]
Charles Swanton | |
---|---|
Born | Robert Charles Swanton 1972 (age 51–52)[1] |
Education | St Paul's School, London |
Alma mater | University College London (MD, PhD) |
Awards | Ellison–Cliffe Lecture (2017) EMBO Member (2017) |
Scientific career | |
Fields | Cancer evolution[2] |
Institutions | Francis Crick Institute University College London |
Thesis | Viral cyclin disruption of mammalian cell cycle control mechanisms (1998) |
Doctoral advisor | Nic Jones |
Website | www |
This section needs expansion. You can help by adding to it. (June 2024) |
Swanton was born in Poole, Dorset. As of 2017, his father Robert Howard Swanton (MD, FRCP) was a consultant cardiologist at UCL.[10]
Swanton was educated at St Paul's School, London[1] and completed his PhD in 1999[11] at what was then the Imperial Cancer Research Fund Laboratories (now the Francis Crick Institute) and his Cancer Research UK clinician scientist/medical oncology training in 2008.[7]
Swanton has combined [when?] his laboratory research with clinical duties as co-director of the CRUK Lung Cancer Centre, focussed on how tumours evolve over space and time.[7] He has helped to define the branched evolutionary histories of solid tumours, processes that drive cancer cell-to-cell variation in the form of new cancer mutations or chromosomal instabilities, and the impact of such cancer diversity on effective immune surveillance and clinical outcome.[2][7][12][13]
As of 2018, Swanton has been a co-founder of Achilles Therapeutics[14] with Sergio Quezada, Karl Peggs and Mark Lowdell. Achilles Therapeutics is a UCL/CRUK and Francis Crick Institute[15] biotechnology company funded by Syncona[16] that develops adoptive T cell therapies targeting clonal/truncal neo-antigens present in every tumour cell to limit drug resistance and tumour evolution.[citation needed]
This section needs expansion. You can help by adding to it. (June 2024) |
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.